Candidiasis
MONDO:0002026Infection with the organism Candida.
Also known as: Candida <Debaryomycetaceae> infection, Candida infection, Candidosis, thrush, disseminated candidiasis, systemic candidiasis, infections, Candida <Debaryomycetaceae>
59 clinical trials for this condition and its sub-types, 19 tagged with Candidiasis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Candidiasis
-
Cutaneous candidiasis 0 trials · 25 incl. sub-types
1 sub-type
- Vulvovaginal candidiasis 25 trials
-
Candidiasis, invasive 14 trials · 18 incl. sub-types
1 sub-type
- Candidemia 13 trials
-
Disseminated candidiasis 16 trials
-
Oral candidiasis 4 trials
-
Neonatal candidiasis 1 trial
-
Candida glabrata infection 0 trials
-
Candidal paronychia 0 trials
-
Congenital candidiasis 0 trials
-
Esophageal candidiasis 0 trials
-
Nanochitosan paste takes on denture fungal infections
Disease control CompletedResearchers are testing whether a 5% nanochitosan paste can treat oral candidosis, a fungal infection common under dentures. The trial compares this experimental paste with a standard nystatin ointment in 30 adults who wear full dentures and have type 2 denture stomatitis. Partic…
Phase 2 • Sponsor: Kerman University of Medical Sciences • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Shrimp-Derived nanoparticles take on denture fungus
Disease control CompletedThis study compares a new 1% nanochitosan solution to standard nystatin oral suspension for treating Newton's type II denture stomatitis, a fungal infection causing redness and inflammation under dentures. The trial enrolls 30 complete denture wearers diagnosed by an oral special…
Phase 2 • Sponsor: Kerman University of Medical Sciences • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New drug shows promise against superbug fungus in small trial
Disease control CompletedThis Phase 2 trial tested an experimental antifungal drug called APX001 (fosmanogepix) in 9 adults with blood or deep-organ infections caused by Candida auris, a fungus that often resists standard treatments. The drug was given by IV or mouth for up to 42 days. The goal was to se…
Phase 2 • Sponsor: Basilea Pharmaceutica • Aim: Disease control
Last updated Jun 26, 2026 17:48 UTC
-
Newborn fungal infection study tests two drugs head-to-head
Disease control CompletedThis study compared two antifungal drugs, fluconazole and micafungin, in 100 newborns with suspected or confirmed candidiasis. The goal was to see if micafungin works as well as the standard treatment fluconazole and to check their safety. The study also looked at how the drugs b…
Phase 2/3 • Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Disease control
Last updated Jun 26, 2026 13:54 UTC
-
Can a quick PCR test speed up lifesaving fungal infection diagnosis?
Diagnosis CompletedThis pilot study explores whether a PCR-based test can deliver faster results for diagnosing invasive candidiasis in intensive care patients. The trial compares the time to results using this new strategy against standard methods, with the hope of enabling earlier, more targeted …
Sponsor: University Hospital, Toulouse • Aim: Diagnosis
Last updated Aug 13, 2026 00:00 UTC
-
New drug could shield transplant patients from deadly fungal infections
Prevention CompletedThis study tested a new medicine called rezafungin to see if it can prevent serious fungal infections in adults getting a bone marrow transplant. About 600 participants received either rezafungin or the standard treatment. The goal was to see if rezafungin helps more people stay …
Phase 3 • Sponsor: Mundipharma Research Limited • Aim: Prevention
Last updated Jun 27, 2026 12:07 UTC
-
Did pandemic precautions lower fungal infections? hospital records hold clues
Knowledge-focused CompletedResearchers reviewed hospital records from 1,441 patients to compare fungal infection rates during the SARS-CoV-2 pandemic and afterward. They calculated positivity rates for Candida and Aspergillus species and other fungi. The study examines whether infection control measures ch…
Sponsor: Bekir Sami Uyanık • Aim: Knowledge-focused
Last updated Sep 21, 2026 20:00 UTC
-
New study aims to catch deadly fungal infections earlier in ICUs
Knowledge-focused CompletedThis study looked at better ways to detect Candida (a type of fungus) infections early in intensive care unit (ICU) patients. Researchers tested 422 non-neutropenic adults who had been in the ICU for more than 48 hours. They used four different tests, including blood tests and sw…
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC
-
Blood marker may spot hidden fungal infections in ICU patients
Knowledge-focused CompletedThis study looked at whether a substance called β-D-glucan in the blood can help identify and track fungal infections in the abdomen (peritonitis) in intensive care patients. Researchers measured levels in 70 adults with peritonitis, comparing those with and without Candida yeast…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 26, 2026 18:49 UTC